Activator of hypoxia tolerance gene hif-1alpha and application thereof

By developing HIF-1α polypeptide activator, the hypoxia tolerance of heterogeneous silver carp is improved, the growth inhibition and immunity reduction caused by hypoxia stress are solved, and the survival rate in low-oxygen water bodies is significantly improved, thus achieving It has efficient and safe low oxygen tolerance effect.

CN119039416APending Publication Date: 2024-11-29TONGWEI AGRI DEV CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411246864.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-06
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

Hypoxic stress leads to inhibition of growth of heterogeneous silver carp, decreased immunity and frequent diseases. Existing aerobic equipment cannot completely solve the problem of hypoxic stress caused by high-density breeding, affecting the sustainable development of the breeding industry.

Method used

Develop an activator of the hypoxia-tolerant gene, HiF-1α polypeptide, which has efficient activation of the HiF-1α gene, improves the hypoxia tolerance and survival rate of heterogeneous silver carp. By injecting the activator, it can improve the HiF -1α expression level and expression of related regulatory genes.

Benefits of technology

It significantly improves the low-oxygen tolerance and survival rate of heterogeneous silver carp, reduces the mortality rate in a low-oxygen environment, and has the advantages of high efficiency, strong specificity, safety and reliability. The mortality rate is reduced by more than 16.12% within 12 hours of injection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0005031395440000011
    Figure HDA0005031395440000011
  • Figure HDA0005031395440000012
    Figure HDA0005031395440000012
  • Figure HDA0005031395440000021
    Figure HDA0005031395440000021
Patent Text Reader

Abstract

The invention provides an activating agent of a hypoxia tolerance gene hif-1alpha and application of the activating agent, and belongs to the technical field of physiological regulation of aquatic animals. The activating agent of the hypoxia tolerance gene hif-1alpha provided by the invention is HIF-1alpha polypeptide, and the amino acid sequence of the HIF-1alpha polypeptide is any one of SEQ ID NO. 1 to SEQ ID NO. 3. The activating agent for the hypoxia tolerance gene hif-1alpha provided by the invention can be used for conveniently, quickly and efficiently activating the hif-1alpha gene, so that the hypoxia tolerance of the carassius auratus gibelio and the survival rate of the carassius auratus gibelio in a hypoxia water body are improved, and the activating agent has the advantages of high activating efficiency, strong specificity, safety and reliability. The activating agent provided by the invention can reduce the death rate of the carassius auratus gibelio in a low-oxygen environment by 16.12% or above within 12 hours after being injected.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of physiological regulation of aquatic animals, and in particular relates to an activator of a hypoxia tolerance gene hif-1α and application thereof. Background Art

[0002] Crucian carp (Carrassius auratusgibeilo) is one of the common freshwater fish. Crucian carp is an omnivorous fish with a wide diet, strong adaptability, strong fertility, strong disease resistance, fast growth, low water temperature requirements, and is easy to breed. In addition, crucian carp has delicious meat and rich nutrition, and has always been favored by consumers. Heterobrious silver crucian carp, whose full name is "heterobrious gynogenetic silver crucian carp", is a silver crucian carp with natural gynogenetic development in Shuangfeng Reservoir, Fangzheng County, Heilongjiang Province as the female parent and Xingguo red carp as the male parent, and the offspring of heterobrious gynogenetic development after artificial insemination. With the annual increase in the production of heterbrious silver crucian carp and the continuous increase in breeding density, it often suffers from hypoxia stress to varying degrees. Hypoxia is one of the important stressors for animals facing environmental, disease, and metabolic changes, which can cause the body's free radical homeostasis to be unbalanced and damage cells. In aquaculture, hypoxia stress often leads to growth inhibition, decreased immunity, frequent diseases and other problems. If hypoxia stress is long-term, it will cause a large number of deaths and cause great economic losses. Although oxygenation equipment can increase the dissolved oxygen in the breeding pond to a certain extent, this method cannot completely solve the problem of hypoxia stress caused by high-density breeding. Therefore, constructing a method to improve the hypoxia tolerance of silver crucian carp is of great significance to the sustainable development of silver crucian carp breeding industry.

[0003] The effects of hypoxia on animal bodies are mainly concentrated in the hypoxia-inducible factor 1 (HIF-1) signaling pathway. The core of hypoxic stress initiation is HIF-1, which plays an important regulatory role in the physiological changes of oxygen-sensitive organs (such as heart, lungs, bones, etc.) and metabolically active tissues (such as mammary glands). The expression changes of HIF-1α depend on the changes in oxygen concentration, while the changes in HIF-1β are not directly affected by oxygen concentration. As the main oxygen-consuming organs, the heart, brain, lungs, etc. will respond quickly to hypoxia in the body, and maintain metabolic homeostasis by activating signaling pathways such as HIF and changing metabolic patterns. Therefore, it is of great significance to study the HIF-1α gene of the silver crucian carp and develop a HIF-1α activator to improve the hypoxia tolerance of the silver crucian carp. However, the gene activator is a chemical reagent whose main component is abscisic acid, which often has problems such as low activation efficiency and low specificity. Summary of the invention

[0004] In view of this, the purpose of the present invention is to provide an activator of the hypoxia tolerance gene hif-1α, which has the advantages of high activation efficiency, strong specificity, safety and reliability, and can significantly improve the hypoxia tolerance of albigenic crucian carp and the survival rate in hypoxic water.

[0005] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0006] The present invention provides an activator of a hypoxia tolerance gene hif-1α. The activator is a HIF-1α polypeptide, and the amino acid sequence of the HIF-1α polypeptide is any one of SEQ ID NO.1 to SEQ ID NO.3.

[0007] The present invention also provides the use of the above activator in preparing a product for increasing the expression level of the hypoxia tolerance gene hif-1α.

[0008] The present invention also provides application of the activator in preparing a product for improving the hypoxia tolerance of crucian carp.

[0009] Preferably, the crucian carp includes silver carp.

[0010] The present invention also provides the use of the above activator in preparing a product for increasing the expression amount of hypoxia tolerance regulating genes.

[0011] Preferably, the hypoxia tolerance regulatory gene includes at least one of vegf, epo, ho-1, and et1.

[0012] The present invention also provides a method for improving the hypoxia tolerance of the allogynogenetic silver crucian carp, comprising the following steps: injecting the above activator into the allogynogenetic silver crucian carp.

[0013] Preferably, the injection dose is 200-250 ng / g body weight.

[0014] Preferably, the injection site is the abdominal cavity.

[0015] Beneficial effects of the present invention:

[0016] The activator of the hypoxia tolerance gene hif-1α provided by the present invention can activate the hif-1α gene conveniently, quickly and efficiently, thereby improving the hypoxia tolerance of the silver carp and the survival rate in hypoxic water, and has the advantages of high activation efficiency, strong specificity, safety and reliability. The activator provided by the present invention can reduce the mortality rate of the silver carp in a hypoxic environment by more than 16.12% within 12 hours of injection. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] Figure 1The effects of three different HIF-1α polypeptides provided by the present invention on the activation of the hif-1α gene in the gill tissue of allogynogenetic silver crucian carp are shown, wherein if the letters in the shoulder letters of any two groups are different, it indicates that there is a significant difference between the two groups; if the letters in the shoulder letters of any two groups are the same, it indicates that there is no significant difference between the two groups;

[0018] Figure 2 The effect of injection of different doses of exogenous HIF-1α peptide 1 on the expression of hif-1α gene in allogynogenetic crucian carp, where if the letters in the shoulder letters of any two groups are different, it indicates that there is a significant difference between the two groups, and if there are the same letters in the shoulder letters of any two groups, it indicates that there is no significant difference between the two groups;

[0019] Figure 3 The effect of injection of exogenous HIF-1α peptide 1 on the expression level of hypoxia tolerance-related regulatory genes in allogynogenetic crucian carp, where *, **, ***, **** all indicate significant differences between the two groups;

[0020] Figure 4 The effect of injection of exogenous HIF-1α peptide 1 on the mortality of silver crucian carp in hypoxic culture environment, where * indicates a significant difference between the two groups. DETAILED DESCRIPTION

[0021] The present invention provides an activator of the hypoxia tolerance gene hif-1α, wherein the activator is a HIF-1α polypeptide, and the amino acid sequence of the HIF-1α polypeptide is

[0022] MRSWKSSSIGMYGASISRSRSSMAWELKGVFASSVSIANSFSTRSSLNSELMSE

[0023] STWKQYSMGLLGTEEPSPDVEDEFVESGPRSEAEQKGKSSAPVSSLVRTGA(SEQ ID NO.1),

[0024] MNTIMPWIQITSPRHITTCSPRARPPQASTACWLRKVVLCGWRLRPLLSTIPRILSHSALCVSTTFSVALWRGMLSCPCSRP(SEQ ID NO.2) or

[0025] MSAPVSLSCWRKRLETQGRIRAGTGSSWLTQSEGQAGADPAKRECAAGSHHPLGCMEPASLGRDPPWPGS (SEQ ID NO. 3).

[0026] The present invention also provides the use of the above activator in preparing a product for increasing the expression amount of the hypoxia tolerance gene hif-1α or increasing the hypoxia tolerance ability of crucian carp.

[0027] In the present invention, the crucian carp preferably includes silver crucian carp, and the types of the products preferably include reagents or kits.

[0028] The present invention also provides the use of the above activator in preparing a product for increasing the expression amount of hypoxia tolerance regulating genes.

[0029] In the present invention, the hypoxia tolerance regulatory gene preferably includes at least one of vegf, epo, ho-1, and et1.

[0030] The present invention also provides a method for improving the hypoxia tolerance of the allogynogenetic silver crucian carp, comprising the following steps: injecting the above activator into the allogynogenetic silver crucian carp.

[0031] In the method of the present invention, the injection dose is based on the weight of the silver carp, preferably 200-250 ng of the above activator is injected per gram of silver carp, more preferably 210-240 ng of the above activator is injected per gram of silver carp. In the present invention, the injection site is preferably the abdominal cavity.

[0032] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.

[0033] In the following embodiments, unless otherwise specified, all of them are conventional methods.

[0034] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.

[0035] The three HIF-1α polypeptides used in the following examples were all commissioned to be synthesized by Nanjing GenScript Biotechnology Co., Ltd. (Nanjing).

[0036] Example 1

[0037] The polypeptide with the amino acid sequence shown in SEQ ID NO.1 is recorded as HIF-1α polypeptide 1, the polypeptide with the amino acid sequence shown in SEQ ID NO.2 is recorded as HIF-1α polypeptide 2, and the polypeptide with the amino acid sequence shown in SEQ ID NO.3 is recorded as HIF-1α polypeptide 3, and the following test is performed:

[0038] Before the experiment, the silver carp were fasted for 24 hours, and then 240 fish were randomly divided into 4 groups, 60 fish in each group, and placed in 3 experimental barrels (20 fish in each experimental barrel). Before the injection experiment, the silver carp were weighed (average weight 26.54±0.18g), and injected with 200μL saline (control group), 200ng / g body weight HIF-1α polypeptide 1 (HIF-1α-1), 200ng / g body weight HIF-1α polypeptide 2 (HIF-1α-2), and 200ng / g body weight HIF-1α polypeptide 3 (HIF-1α-3) according to their body weight. The polypeptides were dissolved in 200μL saline and injected into the abdominal cavity. The gill tissues of the silver carp were collected 2 hours after the injection to analyze the relationship between different HIF-1α polypeptides and the expression of the gill hif-1α gene.

[0039] The specific analysis method of HIF-1α gene expression is as follows:

[0040] RNA was collected from the gill tissue samples of the carp using RNAiso Plus (Vazyme) reagent. The extracted RNA was tested for concentration and quality using a NanoDrop 2000 spectrophotometer, and RNA with an A260 / 280 of 1.8 to 2.0 was considered to be a template for the next PCR experiment. When performing this operation, all samples or reagents were placed in a 4°C refrigerator or on ice. The primer sequences were Forward primer (5′-3′): CTGCCGATCAGTCTGTCTCC (SEQ ID NO.4) and Reverse primer (5′-3′): TTTGTGGAGTCTGGACCACG (SEQ ID NO.5). The primer sequences were synthesized by Sangon Biotech Co., Ltd. (Shanghai). Real-time fluorescence quantitative PCR was performed using a CFX96 Touch (Bio-Rad) instrument, and gene expression was detected using the One Step kit. Plus RT-PCR Kit (Takara). The reaction system is: 1μL target gene RNA (60ng / μL), 10μL 2×One Step Q Probe Mix, 1μL OneStep Q Probe Enzyme Mix, 0.4μL 50×ROX Reference Dye, 0.4μL Forwardprimer, 0.4μL Reverse primer, 6.8μL RNase free ddH2O. The reaction conditions are: 50℃, 15min, 95℃, 5min; 95℃ 10s, 60℃ 30s, 40 cycles; melting curve 71℃. The internal reference gene used in the experiment is β-actin, and the primer sequences are Forwardprimer (5′-3′): TCCATTGTTGGACGACCCAG (SEQ ID NO.6) and Reverseprimer (5′-3′): TGGGCCTCATCTCCCACATA (SEQ ID NO.7). Use 2 -ΔΔCt method to detect gene expression.

[0041] The results are as follows Figure 1 As shown, compared with the control group, the three HIF-1α polypeptides provided by the present invention have significantly higher activation effects on HIF-1α than the control group.

[0042] Example 2

[0043] Effect of injection of exogenous HIF-1α polypeptide 1 (SEQ ID NO.1) on the expression of hif-1α gene in allogynogenetic crucian carp and determination of the optimal injection dose

[0044] Before the experiment, the silver carp was fasted for 24 hours, and then 420 fish were randomly divided into 7 groups, each with 60 fish, and placed in 3 experimental barrels (20 fish in each experimental barrel). Before the injection experiment, the silver carp was weighed (average weight 20.06 ± 0.12g), and injected with 150 μL of saline (control group, Saline), 50, 100, 150, 200, 250, 300 ng / g body weight (BW) of HIF-1α polypeptide 1 according to the body weight. The HIF-1α polypeptide 1 was dissolved using 150 μL of saline, and the injection site was the abdominal cavity. Gill tissue was collected 2 hours after injection to analyze the effects of different injection doses of exogenous HIF-1α polypeptide 1 on the expression of the hif-1α gene of the silver carp. The analysis method of the expression of the hif-1α gene was the same as in Example 1.

[0045] The results are as follows Figure 2As shown, compared with the saline group, the gene expression of hif-1α in the allogynogenetic silver carp treated with 200 and 250 ng / g body weight of HIF-1α peptide 1 was significantly higher than that in the control group and other injection treatment groups (P<0.05). Among them, the dose of HIF-1α peptide 1 injected in the group with the highest expression of hif-1α gene was 250 ng / g body weight.

[0046] Example 3

[0047] Effects of injection of exogenous HIF-1α polypeptide 1 (amino acid sequence as shown in SEQ ID NO.1) on the expression levels of hypoxia tolerance-related regulatory genes in the gills of Allogene crucian carp

[0048] Before the experiment, the silver crucian carp was fasted for 24 hours, and 120 fish were randomly divided into two groups, 60 fish in each group, and placed in three experimental barrels (20 fish in each experimental barrel). Before the injection experiment, the silver crucian carp was weighed (average weight 20.35±0.10g), and injected with 250μL of saline (control group, Reference gene) and 250ng / g body weight of HIF-1α polypeptide 1 according to the body weight. The polypeptide was dissolved in 250μL of saline, and the injection site was the abdominal cavity. After the injection experiment, the gill tissue of 9 fish bodies in each group was collected 2h after the injection (3 in each experimental barrel). The expression level of hypoxia tolerance-related regulatory genes was analyzed, and the specific PCR method was the same as Example 1. The primer sequences of the relevant genes are as follows:

[0049] The primer sequence of vegf is

[0050] Forwardprimer (5′-3′): ATCGAGCACACGTACATCCC (SEQ ID NO.8);

[0051] Reverse primer (5′-3′): CCTTTGGCCTGCATTCACAC (SEQ ID NO.9);

[0052] The primer sequence for epo is

[0053] Forwardprimer (5′-3′): CGAAGTGTCAGCATACCGGA (SEQ ID NO. 10);

[0054] Forwardprimer (5′-3′): GCAGATGACGCACTTTTCCC (SEQ ID NO. 11);

[0055] The primer sequence of ho-1 is

[0056] Forwardprimer (5′-3′): GCAACCAAGAGAAGCCACC (SEQ ID NO. 12);

[0057] Forwardprimer (5′-3′): GGAAGTAGACGGGCTGAACC (SEQ ID NO. 13);

[0058] The primer sequence of et1 is

[0059] Forwardprimer (5′-3′): TAAAGCAGCGTCAGACAGGG (SEQ ID NO. 14);

[0060] Forwardprimer (5′-3′): CTGCCAGCTTTGTGTTTGCAT (SEQ ID NO. 15).

[0061] The results are as follows Figure 3 As shown, compared with the saline group, injection of HIF-1α polypeptide 1 can significantly increase the expression of hypoxia tolerance regulation-related genes vegf, epo, ho-1, and et1. This shows that the HIF-1α polypeptide 1 provided by the present invention for improving the hypoxia tolerance gene hif-1α of the albiculture crucian carp can effectively activate the expression of hypoxia tolerance-related genes regulated by hif-1α downstream to improve hypoxia tolerance.

[0062] Example 4

[0063] Effect of injection of exogenous HIF-1α polypeptide 1 (amino acid sequence as shown in SEQ ID NO.1) on mortality of carp in hypoxic environment

[0064] Before the experiment, the silver carp were fasted for 24 hours. 360 fish were randomly divided into two groups, 180 fish in each group. Each fish was injected with 250 μL saline (control group, Saline) and 250 ng / g body weight of HIF-1α peptide 1 (recorded as Unfed group) according to body weight. The peptide was dissolved in 250 μL saline and injected into the abdominal cavity. Three experimental barrels (60 fish in each experimental barrel) with dissolved oxygen level <1 mg / L were placed respectively, and the silver carp were weighed (average weight 21.11±0.11g). During the experiment, nitrogen was introduced to keep the dissolved oxygen level <1 mg / L. The number of deaths was counted every 3 hours, and the number of deaths of silver carp within 12 hours was counted cumulatively to calculate the mortality rate of silver carp under hypoxia.

[0065] The results are as follows Figure 4As shown, compared with the saline group, the mortality rate of the experimental groups injected with HIF-1α polypeptide 1 at 3h, 6h, 9h and 12h was significantly reduced. At 12h, the average mortality rate of the saline injection group was 80.56%, and the average mortality rate of the experimental group injected with HIF-1α polypeptide 1 was 64.44%. Therefore, injection of HIF-1α polypeptide 1 within 12h can reduce the mortality rate by about 16.12%. It shows that the HIF-1α polypeptide provided by the present invention that improves the hypoxia tolerance gene hif-1α of the albiculture crucian carp can effectively improve the survival rate of the albiculture crucian carp in hypoxic water.

[0066] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. An activator of the hypoxia tolerance gene HIF-1α, It is characterized in that The activator is a HIF-1α polypeptide, and the amino acid sequence of the HIF-1α polypeptide is any one of SEQ ID NO.1 to SEQ ID NO.

3.

2. Use of the activator according to claim 1 in the preparation of a product for increasing the expression level of the hypoxia tolerance gene hif-1α.

3. Use of the activator according to claim 1 in the preparation of a product for improving the hypoxia tolerance of crucian carp.

4. The use according to claim 3, It is characterized in that The crucian carp includes the silver carp.

5. Use of the activator according to claim 1 in the preparation of a product for increasing the expression of hypoxia tolerance regulatory genes.

6. The use according to claim 5, It is characterized in that The hypoxia tolerance regulatory gene includes at least one of vegf, epo, ho-1, and et1.

7. A method for improving hypoxia tolerance of silver carp, It is characterized in that The method comprises the following steps: injecting the activator described in claim 1 into the allogynogenetic silver crucian carp.

8. The method according to claim 7, It is characterized in that The injection dose is 200-250 ng / g body weight.

9. The method according to claim 7, It is characterized in that The injection site is the abdominal cavity.